SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein

The Omicron (BA.1/B.1.1.529) variant of SARS-CoV-2 harbors an alarming 37 mutations on its spike protein, reducing the efficacy of current COVID-19 vaccines. In this study, we identified CD8+ and CD4+ T cell epitopes from SARS-CoV-2 S protein mutants. To identify the highest quality CD8 and CD4 epit...

Descripción completa

Detalles Bibliográficos
Autores principales: Parn, Simone, Savsani, Kush, Dakshanamurthy, Sivanesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624113/
https://www.ncbi.nlm.nih.gov/pubmed/36337685
http://dx.doi.org/10.1016/j.immuno.2022.100020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624113/
https://www.ncbi.nlm.nih.gov/pubmed/36337685
http://dx.doi.org/10.1016/j.immuno.2022.100020

Ejemplares similares